Pursuant to Regulation 29(1) (a) & (2) of the SEBI (LODR) Regulations, 2015, Kabra Drugs has informed that a Meeting of the Board of Directors of the Company will be held on Monday, August 14, 2023 at 4:00 pm to consider and approve, the Un-Audited Financial Results of the Company for the quarter ended on June 30, 2023. Further, the Trading Window for dealing in shares of the Company is already closed and shall open 48 hours after conclusion of the Board Meeting.
The above information is a part of company’s filings submitted to BSE.
